Company: COHN
Filing Date: 2025-03-12
Form Type: 10-K
Source: 0001437749-25-007158
Chunk: 2362

Company: Cohen & Co Inc.
Filing Date: 2025-03-12
Form: 10-K
Item: Item 4
Chunk 2362
---
 have not yet distributed shares to sponsor investors and other equity method investments.  If these SPAC sponsor entities are unsuccessful in completing a business combination and the underlying SPAC liquidates, the Company will likely receive no distributions in kind or in cash related to these investments and the remaining balances will be recorded as a component of loss from equity method investments in the consolidated statement of operations.

        F-
       38

   The following tables show certain summary financial data of all the Company's equity method investees.  These amounts include all equity method investees whether accounted for under the equity method or at fair value.  All information is presented on a combined basis.

       December 31, 2024    December 31, 2023  
 Total Assets  $620,512  $628,495 

 Liabilities  $317,160  $329,661 
 Equity allocable to the controlling interest   303,227   298,709 
 Noncontrolling interest   125   125 
 Total Equity   303,352   298,834 
 Total Liabilities & Equity  $620,512  $628,495 

       Year Ended December 31,  
   2024    2023    2022  
             
 Net income/(loss)  $19,618  $17,858  $(100,481)
 Net income/(loss) attributable to the investee  $19,603  $17,843  $(100,495)

   ﻿ 

        F-
       39

   13. GOODWILL 
   ﻿ 
   Goodwill is comprised of the following.
    
   ﻿ 
   ﻿ 
   ﻿ 
    GOODWILL 
 (Dollars in Thousands) 

       December 31, 2024    December 31, 2023  
 AFN  $109  $109 
 Goodwill  $109  $109 

   The annual impairment testing date for AFN goodwill is  October 1. The first testing date following the AFN Merger was  October 1, 2010. The Company determined the goodwill was not impaired as of 2024, 2023, and 2022. The Company concluded there was no triggering event for the goodwill related to AFN.

        F-
       40

   14. LE